Table 1 Patient demography and clinical information

From: Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer

Parameters

Categories

Values (%)

Age

<56 (Median)

47 (48.0%)

≥56 (Median)

51 (52.0%)

Gender

Male

39 (39.8%)

Female

59 (60.2%)

Grade

Grade-1

68 (69.39%)

Grade-2

26 (26.53%)

Grade-3

2 (2.04%)

Sarcomatoid variant

2 (2.04%)

Stage

I

1 (1.0%)

II

25 (25.5%)

III

33 (33.7%)

IV

32 (32.7%)

NA

7 (7.1%)

Sample type

Local recurrent

3 (3.1%)

Primary

94 (95.9%)

Metastatic

1 (1.0%)

Neo adjuvant treatment given

Yes

14 (14.3%)

No

76 (77.5%)

NA

8 (8.2%)

Tumor site

Buccal mucosa

45 (45.9%)

Tongue

17 (17.4%)

Alveolus

10 (10.2%)

Gingivobuccal sulcus (GBS)

7 (7.1%)

Lip

5 (5.1%)

Oral cavity

9 (9.2%)

Non-oral cavity

5 (5.1%)